Russell Investments Group
PDLI

Russell Investments Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Russell Investments Group’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-196,783
Closed -$485K – 3282
2020
Q4 		$485K Sell
196,783
-633,097
-76% -$1.54M ﹤0.01% 2445
2020
Q3 		$2.62M Buy
829,880
+123,496
+17% +$394K 0.01% 1513
2020
Q2 		$2.05M Buy
706,384
+26,954
+4% +$85.2K ﹤0.01% 1612
2020
Q1 		$1.92M Sell
679,430
-326,532
-32% -$1.05M 0.01% 1489
2019
Q4 		$3.26M Buy
1,005,962
+73,578
+8% +$214K 0.01% 1459
2019
Q3 		$2.02M Buy
932,384
+498,528
+115% +$1.33M ﹤0.01% 1681
2019
Q2 		$1.36M Sell
433,856
-70,335
-14% -$228K ﹤0.01% 1859
2019
Q1 		$1.88M Sell
504,191
-95,659
-16% -$323K ﹤0.01% 1750
2018
Q4 		$1.73M Sell
599,850
-165,782
-22% -$455K ﹤0.01% 1683
2018
Q3 		$2.01M Sell
765,632
-422,489
-36% -$1.04M ﹤0.01% 1750
2018
Q2 		$2.77M Sell
1,188,121
-1,060,343
-47% -$2.96M 0.01% 1597
2018
Q1 		$6.61M Buy
2,248,464
+225,698
+11% +$616K 0.01% 1198
2017
Q4 		$5.84M Sell
2,022,766
-14,900
-0.7% -$45.8K 0.01% 1254
2017
Q3 		$6.91M Buy
2,037,666
+87,888
+5% +$244K 0.01% 1112
2017
Q2 		$4.82M Sell
1,949,778
-235,953
-11% -$543K 0.01% 1262
2017
Q1 		$4.96M Buy
2,185,731
+249,671
+13% +$552K 0.01% 1215
2016
Q4 		$4.1M Buy
+1,936,060
New +$5.4M 0.01% 1362

Other funds holding PDLI

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Russell Investments Group's PDLI Position: Q1 2021 in Review

Russell Investments Group sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 196,783 shares — an estimated $485K sold.

Russell Investments Group first reported a position in PDLI in Q4 2016 and held it in 17 quarters. The position peaked at $6.91M in Q3 2017. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.

  • Russell Investments Group reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
  • Russell Investments Group sold 196,783 PDL BioPharma, Inc. shares in Q1 2021, an estimated $485K.
  • Russell Investments Group first reported a position in PDL BioPharma, Inc. in Q4 2016 and held it in 17 quarters.
  • Russell Investments Group's PDL BioPharma, Inc. position peaked at $6.91M in Q3 2017.
  • 11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.

Based on Russell Investments Group's 13F filing for Q1 2021, filed 10 May 2021.